"It warms my heart to see that the kids see him for who he is," Levi Buxman's mom said of his classmates cheering him on WKYC Channel 3/Youtube A community rallies around an 11-year-old boy two years ...

BRANDENBURG, Ky. (WAVE) - A David T. Wilson Elementary School student in Meade County on Wednesday surprised her classmates, after missing weeks of class, due to a cancer diagnosis. Emmalee Wilkins ...

Researchers at the CU Anschutz Cancer Center have discovered how breast cancer cells that spread to the lungs may take advantage of the body's natural healing response and how a commonly used drug ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

Survivor Casey Liening discusses her metastatic breast cancer journey, reaching NED, and why a stage 4 diagnosis is a beginning, not a death sentence. For many, a stage 4 breast cancer diagnosis can ...

Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...

The sarcoma and follicular lymphoma drug tazemetostat (Tazverik) is being voluntarily pulled from the US and all other markets due to the risk of secondary hematologic malignancies, according to ...

Real-world effectiveness and treatment patterns in patients with locally advanced or metastatic urothelial carcinoma receiving avelumab first-line maintenance in Japan: Long term follow-up from the ...

University researchers have pioneered a new tool to determine the risk of secondary heart attacks in cancer patients using Artificial Intelligence. Cancer patients who suffer a heart attack face ...

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against it. Instead of attacking cancer cells head-on, the experimental ...

Please provide your email address to receive an email when new articles are posted on . Non-lung secondary cancers can develop in survivors of lung cancer years after completion of definitive therapy.